In the case of stageI–II ErbB2-positive breast cancer, the risk of local recurrence and therisk of distant metastasis are 2.7-fold and 5.3-fold higher, respectively, thanthat of a ErbB2-negative cancer [2]. The gene discussed is ERBB2; the disease is cancer.